Quantcast
Last updated on April 19, 2014 at 9:20 EDT

Latest Linden Capital Partners Stories

2013-02-19 08:32:54

GARDEN GROVE, Calif., Feb. 19, 2013 /PRNewswire/ -- HYCOR Biomedical, Inc. ("HYCOR"), a leading manufacturer and marketer of in vitro diagnostic products for the global allergy and autoimmune markets, today announced that it has sold its urinalysis business to an affiliate of One Rock Capital Partners, Laurel Crown Partners, and StoneCreek Capital. The sale includes the KOVA(®) system of urinalysis products. HYCOR is a portfolio company of Linden Capital Partners ("Linden"). "The...

2013-01-31 16:27:04

ST. LOUIS, Jan. 31, 2013 /PRNewswire/ -- Young Innovations, Inc. ("Young" or the "Company") today announced the completion of its acquisition by affiliates of Linden Capital Partners ("Linden") in an all-cash transaction valued at approximately $314 million. As previously announced, the transaction was approved by Young shareholders at a special meeting of shareholders held January 30, 2013. Pursuant to the terms of the agreement and plan of merger, Young's shareholders are entitled...

2013-01-30 16:25:44

ST. LOUIS, Jan. 30, 2013 /PRNewswire/ -- Young Innovations, Inc. (Nasdaq: YDNT) ("Young" or the "Company") announced that, at a special meeting of shareholders held today, its shareholders voted to adopt the Agreement and Plan of Merger, dated as of December 3, 2012, providing for the acquisition of the Company by an affiliate of Linden Capital Partners. Linden Capital Partners is a Chicago-based private equity firm that focuses on middle market leveraged buyout investments in the healthcare...

2013-01-03 16:23:47

ST. LOUIS, Jan. 3, 2013 /PRNewswire/ -- Young Innovations, Inc. (Nasdaq: YDNT) (the "Company" or "Young") today announced that it will hold a special meeting of shareholders on January 30, 2013 at 10:00 a.m. (CST) at the offices of McDermott Will & Emery LLP, 227 West Monroe Street, Chicago, Illinois. At the special meeting, shareholders of the Company will be asked to consider and vote upon a proposal to adopt the previously announced Agreement and Plan of Merger (the "Merger Agreement")...

2012-12-04 08:29:14

ST. LOUIS, Dec. 4, 2012 /PRNewswire/ -- Young Innovations, Inc. (Nasdaq: YDNT) (the "Company" or "Young") today announced that it has entered into a definitive agreement to be acquired by an affiliate of Linden Capital Partners, a Chicago-based private equity firm that focuses on middle market leveraged buyout investments in the healthcare and life science industries. Under the terms of the agreement, holders of outstanding shares of common stock of Young will receive $39.50 per share,...

2012-05-15 06:29:33

ALEXANDRIA, Va., May 15, 2012 /PRNewswire/ -- Oxford Finance LLC ("Oxford"), a specialty finance firm that provides senior debt to life sciences and healthcare services companies, today announced that it participated in the issuance of a senior secured credit facility for Linden Capital Partners, a private equity firm that focuses on middle market leveraged buyout investments in the healthcare and life sciences industries. Proceeds of the debt financing were used to acquire SeraCare Life...

2012-02-13 05:46:00

MILFORD, Mass., Feb. 13, 2012 /PRNewswire/ -- SeraCare Life Sciences, Inc. (NASDAQ: SRLS), a global life sciences company providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics, today announced that it has entered into a definitive agreement to be acquired by an affiliate of Linden Capital Partners, a Chicago-based private equity firm that focuses on middle market leveraged buyout investments in the...

2011-11-10 06:00:00

CHICAGO, Nov. 10, 2011 /PRNewswire/ -- Linden Capital Partners, a Chicago-based private equity firm that focuses on middle market leveraged buyout investments in the healthcare sector, today announced the addition of Chris M. Kolber as an operating partner. Mr. Kolber was a member of the Hospira executive team in the 2004 spin out from Abbott Laboratories and recently served as president, Global Devices, a $1 billion segment of Hospira's business. He is a 30-year veteran of the healthcare...

2011-11-08 06:00:00

LEXINGTON, Mass., Nov. 8, 2011 /PRNewswire/ -- StrataDx, a leader in anatomic pathology, has named former LabCorp executive, Pat Noland, CEO. Since 1984, StrataDx has partnered with clinicians to provide the best care to patients through its high-quality pathology services in the dermatology, urology, podiatry, oral pathology, gastroenterology, and gynecology segments. Mr. Noland's appointment is a key milestone for StrataDx following the recent equity investment by Linden Capital...

2010-06-25 08:30:00

CHICAGO, June 25 /PRNewswire/ -- Linden LLC, a Chicago-based healthcare focused private equity firm, today announced that it has successfully completed fundraising for Linden Capital Partners II ("LCP II"), which closed with $375 million of committed capital and exceeded its target of $300 million and initial cap of $350 million. Linden's second fund continues the strategy from its first fund, executed through industry specialization in healthcare and life science, a focus on building...